Lv71
4370 积分 2024-02-27 加入
Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trial
26天前
已完结
Defects in antigen processing and presentation: mechanisms, immune evasion and implications for cancer vaccine development
1个月前
已完结
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
1个月前
已完结
Critical appraisal of the CLSI guideline EP09c “measurement procedure comparison and bias estimation using patient samples”
1个月前
已完结
Frequencies of red blood cell major blood group antigens and phenotypes in the Chinese Han population from Mainland China
1个月前
已完结
The mutation spectrum of the JK‐null phenotype in the Chinese population
1个月前
已完结
Red blood cell genotyping in China
1个月前
已完结
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
3个月前
已完结
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
3个月前
已完结
[Chinese expert consensus on the analytical validation of tumor comprehensive genomic profiling next generation sequencing testing (2024 edition)]
3个月前
已完结
皖公网安备34019202002308
